NEW YORK, Jan. 16, 2024 /PRNewswire/ -- Delcath Systems, Inc. (DCTH) (Nasdaq: DCTH), an interventional oncology company focused on the treatment of primary and metastatic cancers of the liver, today ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback